Med BioGene Will Launch LungExpress Dx in H2, Establish US Office, CEO Says

Med BioGene's CEO said the company is on track to launch its LungExpress assay in the second half of this year and will likely open a US office to support the test, which will initially be offered in a CLIA-compliant partner lab.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories